Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

earnings

A collection of 146 Posts

Health Giants Strike Billion-Dollar Deals Amidst Regulatory Turmoil post image
pharma-industry business earnings

Health Giants Strike Billion-Dollar Deals Amidst Regulatory Turmoil

by Newsdesk
Shifting Dynamics: The Trump Administration's Moves Across Multiple Fronts post image
pharma-industry business earnings

Shifting Dynamics: The Trump Administration's Moves Across Multiple Fronts

by Newsdesk
Trump Calls On Drug Companies For Vaccine Data Amid CDC Shake-Up post image
pharma-industry business earnings

Trump Calls On Drug Companies For Vaccine Data Amid CDC Shake-Up

by Newsdesk
Anlon Healthcare IPO to list on Wednesday; GMP signals muted debut, price and other details here post image
pharma-industry business earnings

Anlon Healthcare IPO to list on Wednesday; GMP signals muted debut, price and other details here

by Newsdesk
The Race to Produce Generic Weight-Loss Drugs: China's Pharmaceutical Surge post image
pharma-industry business earnings

The Race to Produce Generic Weight-Loss Drugs: China's Pharmaceutical Surge

by Newsdesk
India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger post image
pharma-industry business earnings

India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger

by Newsdesk
Top life sciences companies in world set up GCCs in India: EY report post image
pharma-industry business earnings

Top life sciences companies in world set up GCCs in India: EY report

by Newsdesk
India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger post image
pharma-industry business earnings

India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger

by Newsdesk
Global drugmakers rush to boost US presence as tariff threat looms post image
pharma-industry business earnings

Global drugmakers rush to boost US presence as tariff threat looms

by Newsdesk
Drugmakers Boost U.S. Manufacturing Amid Tariff Threats post image
pharma-industry business earnings

Drugmakers Boost U.S. Manufacturing Amid Tariff Threats

by Newsdesk
Pfizer defends COVID-19 vaccine after Trump criticism post image
pharma-industry business earnings

Pfizer defends COVID-19 vaccine after Trump criticism

by Newsdesk
Gilead starts building manufacturing hub under $32 billion planned US investments post image
pharma-industry business earnings

Gilead starts building manufacturing hub under $32 billion planned US investments

by Newsdesk